CYPH
NASDAQ · Biotechnology
Cypherpunk Technologies Inc
$0.69
+0.09 (+14.03%)
Open$0.64
Previous Close$0.61
Day High$0.77
Day Low$0.64
52W High$49.27
52W Low$27.11
Volume—
Avg Volume94.7K
Market Cap39.32M
P/E Ratio—
EPS$-0.79
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+5,479.3% upside
Current
$0.69
$0.69
Target
$38.72
$38.72
$25.17
$38.72 avg
$55.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 17.60M | 17.28M | 16.86M |
| Net Income | 2.07M | 2.55M | 2.09M |
| Profit Margin | 11.8% | 14.8% | 12.4% |
| EBITDA | 4.18M | 3.81M | 3.82M |
| Free Cash Flow | 1.52M | 982.4K | 1.03M |
| Rev Growth | +11.2% | +9.6% | +9.9% |
| Debt/Equity | 0.55 | 0.54 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |